Corrigendum to “Blockade of STAT3 activation by sorafenib derivatives through enhancing SHP-1 phosphatase activity” (Eur. J. Med. Chem. (2012) 55 (220–227)(S0223523412004497)(10.1016/j.ejmech.2012.07.023))

Chen K.-F.Tai W.-T.Hsu C.-Y.Huang J.-W.Liu C.-Y.PEI-JER CHENKim I.Shiau C.-W.2021-07-032021-07-0320180223-5234https://www.scopus.com/inward/record.uri?eid=2-s2.0-85032826314&doi=10.1016%2fj.ejmech.2017.10.053&partnerID=40&md5=cc9053f5bd0e2937b2761feb70ea1d7dhttps://scholars.lib.ntu.edu.tw/handle/123456789/568353Corrigendum to “Blockade of STAT3 activation by sorafenib derivatives through enhancing SHP-1 phosphatase activity” (Eur. J. Med. Chem. (2012) 55 (220–227)(S0223523412004497)(10.1016/j.ejmech.2012.07.023))corrigendum10.1016/j.ejmech.2017.10.053291137442-s2.0-85032826314